全身正电子发射断层扫描/计算机断层扫描在儿科成像中的潜在作用。
Potential Roles of Total-Body PET/Computed Tomography in Pediatric Imaging.
机构信息
Department of Radiology, University of California, Davis, ACC building Suite 3100, Sacramento, California 95817, USA.
Department of Radiology, University of California, Davis, ACC building Suite 3100, Sacramento, California 95817, USA; United Imaging Healthcare of America, Houston, TX, USA.
出版信息
PET Clin. 2020 Jul;15(3):271-279. doi: 10.1016/j.cpet.2020.03.009.
Abstract
In the current diagnostic paradigm, the substantial physical sensitivity gain is the main advantage of total-body (TB) PET/computed tomography (CT). Therefore, it is up to the imaging community to tailor protocols that take advantage of this unique innovation as it relates to the needs of the pediatric population. However, the paradigm-shifting promise of TB-PET/CT lies in its capability to perform dynamic, delayed, and low-dose imaging, which have the potential to vastly increase the range of diseases and disorders that can be investigated or managed using molecular imaging.
摘要
在当前的诊断模式中，全身（TB）PET/计算机断层扫描（CT）的显著物理灵敏度增益是其主要优势。因此，如何制定充分利用这一独特创新的协议取决于成像界，这与儿科人群的需求有关。然而，TB-PET/CT 带来的范式转变的承诺在于其进行动态、延迟和低剂量成像的能力，这有可能极大地增加可以使用分子成像进行研究或管理的疾病和病症的范围。
相似文献
1
Potential Roles of Total-Body PET/Computed Tomography in Pediatric Imaging.
PET Clin. 2020 Jul;15(3):271-279. doi: 10.1016/j.cpet.2020.03.009.
2
Total-Body PET/Computed Tomography Highlights in Clinical Practice: Experiences from Zhongshan Hospital, Fudan University.
PET Clin. 2021 Jan;16(1):9-14. doi: 10.1016/j.cpet.2020.09.007.
3
Oncologic Applications of Long Axial Field-of-View PET/Computed Tomography.
PET Clin. 2021 Jan;16(1):65-73. doi: 10.1016/j.cpet.2020.09.010.
4
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Eur Radiol. 2020 Jul;30(7):3641-3649. doi: 10.1007/s00330-020-06703-1. Epub 2020 Mar 3.
5
Clinical evaluation of CT radiation dose in whole-body F-FDG PET/CT in relation to scout imaging direction and arm position.
Ann Nucl Med. 2019 Mar;33(3):169-176. doi: 10.1007/s12149-018-1318-0. Epub 2018 Nov 10.
6
EFFECTIVE RADIATION DOSE OF 18F-FDG PET/CT: HOW MUCH DOES DIAGNOSTIC CT CONTRIBUTE?
Radiat Prot Dosimetry. 2019 Dec 31;187(2):183-190. doi: 10.1093/rpd/ncz153.
7
Weight-based, low-dose pediatric whole-body PET/CT protocols.
J Nucl Med. 2009 Oct;50(10):1570-7. doi: 10.2967/jnumed.109.065912.
8
Diagnostic performance of F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
Ann Nucl Med. 2018 Jun;32(5):348-362. doi: 10.1007/s12149-018-1254-z. Epub 2018 Apr 17.
9
An Australian local diagnostic reference level for paediatric whole-body F-FDG PET/CT.
Br J Radiol. 2019 Apr;92(1096):20180879. doi: 10.1259/bjr.20180879. Epub 2019 Mar 5.
10
Assessment of Total-Body Atherosclerosis by PET/Computed Tomography.
PET Clin. 2021 Jan;16(1):119-128. doi: 10.1016/j.cpet.2020.09.013. Epub 2020 Nov 5.
引用本文的文献
1
Total-Body Parametric Imaging Using Relative Patlak Plot.
J Nucl Med. 2025 Apr 1;66(4):654-661. doi: 10.2967/jnumed.124.268496.
2
Optimisation of low and ultra-low dose scanning protocols for ultra-extended field of view PET in a real-world clinical setting.
Cancer Imaging. 2025 Jan 30;25(1):7. doi: 10.1186/s40644-025-00823-x.
3
Performance Characteristics of a New Generation 148-cm Axial Field-of-View uMI Panorama GS PET/CT System with Extended NEMA NU 2-2018 and EARL Standards.
J Nucl Med. 2024 Dec 3;65(12):1974-1982. doi: 10.2967/jnumed.124.267963.
4
QUALIPAED-A retrospective quality control study evaluating pediatric long axial field-of-view low-dose FDG-PET/CT.
Front Nucl Med. 2024 Jun 13;4:1398773. doi: 10.3389/fnume.2024.1398773. eCollection 2024.
5
Exploring the nigrostriatal and digestive interplays in Parkinson's disease using dynamic total-body [C]CFT PET/CT.
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2271-2282. doi: 10.1007/s00259-024-06638-5. Epub 2024 Feb 23.
6
Evolving roles of PET/CT and PET/MRI in assessing pediatric disorders with acceptable safety standards.
Eur Radiol. 2024 May;34(5):3249-3251. doi: 10.1007/s00330-023-10385-w. Epub 2023 Nov 2.
7
A third of the radiotracer dose: two decades of progress in pediatric [F]fluorodeoxyglucose PET/CT and PET/MR imaging.
Eur Radiol. 2024 May;34(5):3252-3259. doi: 10.1007/s00330-023-10319-6. Epub 2023 Oct 19.
8
Pilot study on C-CFT dynamic imaging using total-body PET/CT: biodistribution and radiation dosimetry in Parkinson's disease.
Front Neurol. 2023 May 16;14:1153779. doi: 10.3389/fneur.2023.1153779. eCollection 2023.
9
Comparison of the different imaging modalities used to image pediatric oncology patients: A COG diagnostic imaging committee/SPR oncology committee white paper.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e30298. doi: 10.1002/pbc.30298. Epub 2023 Apr 6.
10
Image quality assessment along the one metre axial field-of-view of the total-body Biograph Vision Quadra PET/CT system for F-FDG.
EJNMMI Phys. 2022 Dec 14;9(1):87. doi: 10.1186/s40658-022-00516-5.
本文引用的文献
1
Subsecond total-body imaging using ultrasensitive positron emission tomography.
Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2265-2267. doi: 10.1073/pnas.1917379117. Epub 2020 Jan 21.
2
Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
Int J Rheum Dis. 2019 Dec;22(12):2191-2198. doi: 10.1111/1756-185X.13730. Epub 2019 Nov 13.
3
PennPET Explorer: Human Imaging on a Whole-Body Imager.
J Nucl Med. 2020 Jan;61(1):144-151. doi: 10.2967/jnumed.119.231845. Epub 2019 Sep 27.
4
Total-Body PET and Highly Stable Chelators Together Enable Meaningful Zr-Antibody PET Studies up to 30 Days After Injection.
J Nucl Med. 2020 Mar;61(3):453-460. doi: 10.2967/jnumed.119.230961. Epub 2019 Sep 27.
5
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver.
PET Clin. 2019 Oct;14(4):419-425. doi: 10.1016/j.cpet.2019.06.004. Epub 2019 Aug 6.
6
Lutathera: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy.
Pharmaceuticals (Basel). 2019 Jul 29;12(3):114. doi: 10.3390/ph12030114.
7
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
J Alzheimers Dis. 2019;70(4):1197-1207. doi: 10.3233/JAD-190220.
8
Global disease score (GDS) is the name of the game!
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1768-1772. doi: 10.1007/s00259-019-04383-8. Epub 2019 Jun 10.
9
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.
PET Clin. 2019 Jul;14(3):331-340. doi: 10.1016/j.cpet.2019.03.003. Epub 2019 Apr 10.
10
The Potential Role of Total Body PET Imaging in Assessment of Atherosclerosis.
PET Clin. 2019 Apr;14(2):245-250. doi: 10.1016/j.cpet.2018.12.007.
Zotero 插件